Phase II study of cis-dichlorodiammineplatinum(II) in advanced breast cancer. 1978

H Y Yap, and P Salem, and G N Hortobagyi, and G P Bodey, and A U Buzdar, and C K Tashima, and G R Blumenschein

Twenty-six patients with metastatic breast cancer received cis-dichlorodiammineplatinum(II) either as a single dose of 100 mg/m2 iv every 3--4 weeks or as a continuous 5-day infusion of 20 mg/m2/day at 4-week intervals. Fourteen patients were treated with the single-dose schedule and 12 patients were treated with the continuous 5-day infusion. No significant response was observed with either dose schedule. Aside from a reduction in the frequency and severity of gastrointestinal toxicity with the continuous 5-day infusion, no real difference was seen with regard to renal and hematologic toxicity with either dose schedule.

UI MeSH Term Description Entries
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

H Y Yap, and P Salem, and G N Hortobagyi, and G P Bodey, and A U Buzdar, and C K Tashima, and G R Blumenschein
July 1976, Cancer treatment reports,
H Y Yap, and P Salem, and G N Hortobagyi, and G P Bodey, and A U Buzdar, and C K Tashima, and G R Blumenschein
November 1982, European journal of cancer & clinical oncology,
H Y Yap, and P Salem, and G N Hortobagyi, and G P Bodey, and A U Buzdar, and C K Tashima, and G R Blumenschein
January 1976, Cancer treatment reports,
H Y Yap, and P Salem, and G N Hortobagyi, and G P Bodey, and A U Buzdar, and C K Tashima, and G R Blumenschein
March 1985, Gan to kagaku ryoho. Cancer & chemotherapy,
H Y Yap, and P Salem, and G N Hortobagyi, and G P Bodey, and A U Buzdar, and C K Tashima, and G R Blumenschein
February 1978, Cancer treatment reports,
H Y Yap, and P Salem, and G N Hortobagyi, and G P Bodey, and A U Buzdar, and C K Tashima, and G R Blumenschein
January 1979, Cancer treatment reports,
H Y Yap, and P Salem, and G N Hortobagyi, and G P Bodey, and A U Buzdar, and C K Tashima, and G R Blumenschein
April 1984, Gan to kagaku ryoho. Cancer & chemotherapy,
H Y Yap, and P Salem, and G N Hortobagyi, and G P Bodey, and A U Buzdar, and C K Tashima, and G R Blumenschein
February 1983, American journal of clinical oncology,
H Y Yap, and P Salem, and G N Hortobagyi, and G P Bodey, and A U Buzdar, and C K Tashima, and G R Blumenschein
December 1978, Cancer treatment reports,
H Y Yap, and P Salem, and G N Hortobagyi, and G P Bodey, and A U Buzdar, and C K Tashima, and G R Blumenschein
January 1979, Cancer treatment reports,
Copied contents to your clipboard!